SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-036003
Filing Date
2022-02-11
Accepted
2022-02-11 09:20:59
Documents
1
Group Members
FORBION IV MANAGEMENT B.V.

Document Format Files

Seq Description Document Type Size
1 SC 13G d304927dsc13g.htm SC 13G 55827
  Complete submission text file 0001193125-22-036003.txt   57426
Mailing Address GOOIMEER 2-35 NAARDEN P7 1411 DC
Business Address GOOIMEER 2-35 NAARDEN P7 1411 DC 31 356993000
Forbion Capital Fund IV Cooperatief U.A. (Filed by) CIK: 0001823747 (see all company filings)

IRS No.: 981445896 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW 44 (0)20 8154 4600
Achilles Therapeutics plc (Subject) CIK: 0001830749 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92487 | Film No.: 22617084
SIC: 2836 Biological Products, (No Diagnostic Substances)